Kobayashi, S.; Ohtake, T.; Mochida, Y.; Ishioka, K.; Oka, M.; Maesato, K.; Moriya, H.; Hidaka, S.
Asymmetric Dimethylarginine (ADMA) as a Novel Risk Factor for Progression of Coronary Artery Calcification in Patients with Chronic Kidney Disease. J. Clin. Med. 2025, 14, 1051.
https://doi.org/10.3390/jcm14041051
AMA Style
Kobayashi S, Ohtake T, Mochida Y, Ishioka K, Oka M, Maesato K, Moriya H, Hidaka S.
Asymmetric Dimethylarginine (ADMA) as a Novel Risk Factor for Progression of Coronary Artery Calcification in Patients with Chronic Kidney Disease. Journal of Clinical Medicine. 2025; 14(4):1051.
https://doi.org/10.3390/jcm14041051
Chicago/Turabian Style
Kobayashi, Shuzo, Takayasu Ohtake, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Hidekazu Moriya, and Sumi Hidaka.
2025. "Asymmetric Dimethylarginine (ADMA) as a Novel Risk Factor for Progression of Coronary Artery Calcification in Patients with Chronic Kidney Disease" Journal of Clinical Medicine 14, no. 4: 1051.
https://doi.org/10.3390/jcm14041051
APA Style
Kobayashi, S., Ohtake, T., Mochida, Y., Ishioka, K., Oka, M., Maesato, K., Moriya, H., & Hidaka, S.
(2025). Asymmetric Dimethylarginine (ADMA) as a Novel Risk Factor for Progression of Coronary Artery Calcification in Patients with Chronic Kidney Disease. Journal of Clinical Medicine, 14(4), 1051.
https://doi.org/10.3390/jcm14041051
